2m 2m 2m 2m 2m 2m 2m
UNICYCIVE THERAP (UNCY)
NASDAQ
$7.16-$0.04 (-0.57%)
Price as of Jun 03, 2026 7:55 PM EDT- $197.0MMarket Cap
- -5.24%1-Year Change
- BiotechnologyIndustry
UNICYCIVE THERAP (UNCY)
$7.16-$0.04 (-0.57%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VIVO CAPITAL, LLC | 8.33% | 1.8M | 0 (0.00%) | Mar 31, 2026 |
MILLENNIUM MANAGEMENT LLC | 6.51% | 1.4M | +384,505 (+27.48%) | Mar 31, 2026 |
OCTAGON CAPITAL ADVISORS LP | 4.65% | 1.0M | 0 (0.00%) | Mar 31, 2026 |
NANTAHALA CAPITAL MANAGEMENT, LLC | 4.37% | 939,202 | 0 (0.00%) | Mar 31, 2026 |
N/A | 3.78% | 811,430 | +811,430 (+100.00%) | Mar 31, 2026 |
GREAT POINT PARTNERS LLC | 3.71% | 796,558 | 0 (0.00%) | Mar 31, 2026 |
VANGUARD GROUP INC | 3.67% | 788,587 | +129,709 (+16.45%) | Dec 31, 2025 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 5.64% | 1.2M | 0 (0.00%) | Mar 31, 2026 |
FIDELITY CONCORD STREET TRUST | 2.32% | 497,940 | 0 (0.00%) | Feb 28, 2026 |
iSHARES TRUST | 0.36% | 77,238 | 0 (0.00%) | Feb 28, 2026 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.07% | 15,714 | +15,714 (+100.00%) | Jan 31, 2026 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.03% | 7,337 | 0 (0.00%) | Mar 31, 2026 |
EQ ADVISORS TRUST | 0.03% | 6,004 | 0 (0.00%) | Mar 31, 2026 |
Dimensional ETF Trust | 0.01% | 2,981 | +2,981 (+100.00%) | Jan 31, 2026 |
Current Ownership Distribution
- Institutions268.4M (94.67%)
- Mutual Funds11.7M (4.13%)
- Insiders3.4M (1.20%)
- Other0 (0.00%)
Insider Transactions
- 1.20% (3.4M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Gupta Shalabh K. CEO | Award | Jul 28, 2025 | $0.00 | 325,000 | $0.00 | 968,951 |
Kenkare-Mitra Sara | Award | Jul 28, 2025 | $0.00 | 21,200 | $0.00 | 39,200 |
Aggarwal Gaurav | Award | Jul 28, 2025 | $0.00 | 21,200 | $0.00 | 39,200 |
Laumas Sandeep | Award | Jul 28, 2025 | $0.00 | 21,200 | $0.00 | 41,286 |
Jermasek Douglas EVP of Corporate Strategy | Award | Jul 28, 2025 | $0.00 | 10,000 | $0.00 | 215,500 |
Gupta Pramod EVP, Pharmaceuticals and BD | Award | Jul 28, 2025 | $0.00 | 90,000 | $0.00 | 301,986 |
Townsend John Chief Financial Officer | Award | Jul 28, 2025 | $0.00 | 10,000 | $0.00 | 101,557 |
Aggarwal Gaurav | Return | Feb 18, 2025 | $686,000.00 | 686 | $1,000.00 | 3,119 |
Aggarwal Gaurav | Conversion | Feb 18, 2025 | $0.00 | 1.4M | $0.00 | 11.4M |